While the link between calreticulin-TRAIL cognate interaction and iNKT-dependent tumor killing requires further corroborating research, it would potentially provide a molecular mechanism for the iNKT cell-mediated antitumor effects in a variety of cancers. This evidence concerns the gene CALR and neoplasm.